Research & Development
20 November 2019 - Genmab A/S (CPH:GMAB), a biotechnology company specialising in the creation and development of differentiated antibody therapeutics for the treatment of cancer, announced on Tuesday...
20 November 2019 - Biopharmaceutical company Orphazyme A/S (CPH:ORPHA.CO) announced on Tuesday the grant by the US Food and Drug Administration (FDA) of Breakthrough Therapy Designation for arimoclomo...
19 November 2019 - - British-Swedish pharmaceutical company AstraZeneca (OTC: AZNCF) released new data from five additional analyses of the landmark Phase III DAPA-HF trial, which showed that Farxiga ...
19 November 2019 - - US-based biopharmaceutical company Aveo Oncology (NASDAQ: AVEO) has presented updated data from the Phase 3 TIVO-3 trial.
The data were presented on Saturday, November 16, ...
19 November 2019 - - The United States Food and Drug Administration has approved US-based pharmaceutical company Pfizer Inc.'s (NYSE: PFE) Abrilada (adalimumab-afzb), as a biosimilar to Humira&nb...
19 November 2019 - BioPorto A/S (CPH:BIOPOR), an in vitro diagnostics company, reported on Monday that it will provide additional patient information in support of its US application for regulatory cl...
Related Headlines